The 45 references in paper R. Golubev V., A. Smirnov V., Р. Голубев В., А. Смирнов В. (2017) “РАСШИРЕНИЕ ПРЕДСТАВЛЕНИЙ О МЕХАНИЗМАХ ДЕЙСТВИЯ СУКЦИНАТСОДЕРЖАЩИХ ДИАЛИЗИРУЮЩИХ РАСТВОРОВ // EXPANDING THE FRONTIERS OF SUCCINATE-CONTAINING DIALYSATE’S EFFECTS” / spz:neicon:nefr:y:2017:i:1:p:19-24

1
Cмирнов АВ, Нестерова ОБ, Голубев РВ и др. Кардиопротективные эффекты сукцинатсодержащего диализирующего раствора. Нефрология 2012; 16(2): 69-78 [Smirnov AV, Nesterova OB, Golubev RV i dr. Kardioprotektivnye e’ffekty sukcinatsoderzhashhego dializiruyushhego rastvora. Nefrologiya
(check this in PDF content)
2
12; 16(2): 69-78] 2. Смирнов АВ, Нестерова ОБ, Суглобова ЕД и др. Клинико-лабораторная оценка эффективности лечения больных с терминальной стадией почечной недостаточности с использованием хронического гемодиализа и ацидосукцината. Тер Арх 2013; 85(1): 69-75 [Smirnov AV, Nesterova OB, Suglobova ED i dr. Kliniko-laboratornaya ocenka e’ffektivnosti lecheniya bol’nyh s terminal’noj stadiej pochechnoj nedostatochnosti s ispol’zovaniem hronicheskogo gemodializa i acidosukcinata. Ter Arh 2013; 85(1): 69-75]
(check this in PDF content)
3
Смирнов АВ, Нестерова ОБ, Голубев РВ. Янтарная кислота и её применение в медицине. Часть II. Применение янтарной кислоты в медицине. Нефрология 2014; 18(4): 12-24 [Smirnov AV, Nesterova OB, Golubev RV. Yantarnaya kislota i eyo primenenie v medicine. Chast’ II. Primenenie yantarnoj kisloty v medicine. Nefrologiya 2014; 18(4): 12-24]
(check this in PDF content)
4
Смирнов АВ, Голубев РВ, Васильев АН и др. Гемодинамические эффекты содержащего сукцинат диализирующего раствора. Тер Арх 2015; 87(6): 56-61. doi: 10.17116/ terarkh201587656-61 [Smirnov AV, Golubev RV, Vasil’ev AN i dr. Gemodinamicheskie e’ffekty soderzhashhego sukcinat dializiruyushhego rastvora. Ter Arh 2015; 87(6): 56-61. doi: 10.17116/ terarkh201587656-61]
(check this in PDF content)
5
Смирнов АВ, Нестерова ОБ, Голубев РВ, Лазеба ВА. Сукцинатсодержащие диализирующие растворы в практике гемодиализа. Левша, СПб., 2014; 73-82 [Smirnov AV, Nesterova OB, Golubev RV, Lazeba VA. Sukcinatsoderzhashhie dializiruyushhie rastvory v praktike gemodializa. Levsha, SPb, 2014; 73-82]
(check this in PDF content)
6
Benit P, Letouze E, Rak M et al. Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling. Biochim Biophys Acta 2014; 1837(8): 1330-1337. doi: 10.1016/j.bbabio.2014.03.013
(check this in PDF content)
7
Glissen J, Jouret F, Pirotte B, Hanson J. Insight into SUCNR1 (GPR91) structure and function. Pharmacol Ther 2016; doi: 10.1016/j.pharmthera.2016.01.008 [Epub ahead of print]
(check this in PDF content)
8
Tretter L, Patocs A, Chinopoulos C. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. BBA – Bioenergetics 2016; doi: 10.1016/j.bbabio.2016.03.012 [Epub ahead of print]
(check this in PDF content)
9
Antonio C, Papke C, Rocha M et al. Regulation of primary metabolism in response to low oxygen availability as revealed by carbon and nitrogen isotope redistribution. Plant Physiol 2016; 170(1): 43-56. doi: 10.1104/pp.15.00266
(check this in PDF content)
10
Titov D, Cracan V, Goodman R et al. Complementation of mitochondrial electron transport chain by manipulation of the NAD+/NADH ratio. Science 2016; 352(6282): 231-235. doi: 10.1126/science.aad4017
(check this in PDF content)
11
Kiss G, Konrad C, Pour-Ghaz I et al. Mitochondrial diaphorases as NAD+ donors to segments of the citric acid cycle that support substrate-level phosphorylation yielding ATP during respiratory inhibition. FASEB J 2014; 28(4): 1682-1697. doi: 10.1096/fj.13-243030
(check this in PDF content)
12
Qutub A, Popel A. Three autocrine feedback loops determine HIF1α expression in chronic hypoxia. Biochim Biophys Acta 2007; 1773(10): 1511-1525. doi: 10.1016/j.bbamcr.2007.07.004
(check this in PDF content)
13
Schmid H, Jelkmann W. Investigational therapies for renal disease-induced anemia. Expert Opin Investig Drugs 2016; doi: 10.1080/13543784.2016.1182981 [Epub ahead of print]
(check this in PDF content)
14
Schonenberger M, Kovacs W. Hypoxia signaling pathways: modulators of oxygen-related organelles. Front Cell Dev Biol 2015; 3: 42. doi: 10.3389/fcell.2015.00042
(check this in PDF content)
15
Semenza G. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148(3): 399-408. doi: 10.1016/j. cell.2012.01.021
(check this in PDF content)
16
Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85(3): 1093–1129. doi: 10.1152/physrev.00006.2004
(check this in PDF content)
17
Ingwall JS. Energy metabolism in heart failure and remodeling. Cardiovasc Res 2009; 81(3): 412-419. doi: 10.1093/ cvr/cvn301
(check this in PDF content)
18
Тугушева ФА, Куликова АИ, Коношкова РЛ. О влиянии предуктала-20 на ишемию миокарда и показатели липопероксидации в крови больных с хронической почечной недостаточностью, получающих регулярный гемодиализ. Нефрология 1997; 1(2): 73-78 [Tugusheva FA, Kulikova AI, Konoshkova RL. O vliyanii preduktala-20 na ishemiyu miokarda i pokazateli lipoperoksidacii v krovi bol'nyh s hronicheskoj pochechnoj nedostatochnost’yu, poluchayushhih regulyarnyj gemodializ. Nefrologiya 1997; 1(2): 73-78]
(check this in PDF content)
19
Zhou X, Chen J. Is treatment with trimetazidine beneficial in patients with chronic heart failure? PLOS One 2014, 9(5), e94660. doi: 10.1371/journal.pone.0094660
(check this in PDF content)
20
Anderson E, Xue X, Shah Y. Intestinal hypoxia-inducible factor-2α (HIF-2 α) is critical for efficient erythropoiesis. J Biol Chem 2011; 286(22): 19533-19540. doi: 10.1074/jbc. M111.238667
(check this in PDF content)
21
Barrett TD, Palomino HL, Brondstetter TI et al. Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats. Br J Pharmacol 2015; 172(16): 4078-4088. doi: 10.1111/bph.13188
(check this in PDF content)
22
Titze J, Machnic A. Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens 2010; 19(4): 385-392. doi: 10.1097/MNH.0b013e32833aeb3b
(check this in PDF content)
23
Titze J, Dahlmann A, Lerchl K et al. Spooky sodium balance. Kidney Int 2013; 85(4): 759-767. doi: 10.1038/ki.2013.367
(check this in PDF content)
24
Titze J, Muller DN, Luft FC. Taking another “look” at sodium. Can J Cardiol 2014; 30(5): 473-475. doi: 10.1016/j. cjca.2014.02.006
(check this in PDF content)
25
Murry C, Jennings R, Reimer K. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74(5): 1124–1136. doi: 10.1161/01.CIR.74.5.1124
(check this in PDF content)
26
Kitagawa K, Matsumoto M, Tagaya M. et al. «Ischemic tolerance» phenomenon found in the brain. Brain Res 1990; 528(1): 21–24. doi: 10.1016/0006-8993(90)90189-I
(check this in PDF content)
27
Rybnikova E, Samoilov M. Cuttent insights into the molecular mechanisms of hypoxic pre- and postconditioning using hypobaric hypoxia. Front Neurosci 2015; 9: 388. doi: 10.3389/ fnins.2015.00388
(check this in PDF content)
28
Calabrese V, Cornelius C, Dinkova-Kostova A et al. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal 2010; 13(11): 1763-1811. doi: 10.1089/ars.2009.3074
(check this in PDF content)
29
Samaja M, Milano G. Editorial – Hypoxia and reoxygenation: from basic science to bedside. Front Pediatr 2015; 3: 86. doi:10.3389/fped.2015.00086
(check this in PDF content)
30
Besarab A, Provenzano R, Hertel J et al. Randomised placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients. Neprol Dial Transplant 2015; 30(10): 1665-1673. doi: 10.1093/ndt/gfv302
(check this in PDF content)
31
Provenzano R, Besarab A, Wright S et al. Roxadustat (FG-4592) versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6- to 19-week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study. AJKD 2016; doi: 10.1053/j.ajkd.2015.12.020 [Epub ahead of print]
(check this in PDF content)
32
Lee K, Kim HM. A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor. Arch Pharm Res 2011; 34(10): 1583-1585. doi: 10.1007/s12272-011-1021-3
(check this in PDF content)
33
Hu Y, Liu J, Huang H. Recent agents targeting HIF-1α for cancer therapy. J Cell Biochem 2013; 114(3): 498-509. doi: 10.1002/jcb.24390
(check this in PDF content)
34
Ali S, Oni E, Waraich H et al. Systematic review on noninvasive assessment of subclinical cardiovascular disease in obstructive sleep apnea: new kid on the block! Sleep Med Rev 2014; 18(5): 379-381. doi: 10.1016/j.smrv.2014.01.004
(check this in PDF content)
35
Chouchani E, Pell V, Gaude E et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014; 515(7527): 431-435. doi: 10.1038/ nature13909
(check this in PDF content)
36
Schmidt H, Stocker R, Vollbracht C et al. Antioxidants in translational medicine. Antioxid Redox Signal 2015; 23(14): 11301143. doi: 10.1089/ars.2015.6393
(check this in PDF content)
37
Zhang H, Limphong P, Pieper J et al. Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J 2012; 26(4): 1442-1451. doi: 10.1096/fj.11-199869
(check this in PDF content)
38
Veal E, Day A, Morgan B. Hydrogen peroxide sensing and signaling. Mol Cell Rev 2007; 26(1): 1-14. doi: 10.1016/j. molcel.2007.03.016
(check this in PDF content)
39
Al-Mehdi A-B, Pastukh V, Swiger B et al. Perinuclear mitochondrial clustering creates an oxidant-reach nuclear domain required for hypoxia-induced transcription. Sci Signal 2012; 5(231): ra47. doi: 10.1126/scisignal.2002712
(check this in PDF content)
40
Powers S, Smuder A, Kavazis A, Quindry J. Mechanisms of exercise-induced cardioprotection. Physiology(Bethesda) 2014; 29(1):27-38. doi: 10.1152/physiol.00030.2013
(check this in PDF content)
41
Ristow M, Zarse K, Oberbach A et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009; 106(21): 8665–8670. doi: 10.1073/ pnas.0903485106
(check this in PDF content)
42
Merkley E, Metz T, Smith R. The succinated proteome. Mass Spectrom Rev 2014; 33(2): 98-109. doi: 10.1002/mas.21382
(check this in PDF content)
43
Kuo C-Y, Cheng C-T, Hou P et al. HIF-1-alpha links mitochondrial perturbation to the dynamic acquisition of breаst cancer tumorigenicity. Oncotarget 2016; doi: 10.18632/oncotarget.8570 [Epub ahead of print]
(check this in PDF content)
44
Gibson G, Xu H, Chen H-L et al. Alpha-ketoglutarate dehydrogenase complex-dependent succinilation of proteins in neurons and neuronal cell lines. J Neurochem 2015; 134(1): 8696. doi: 10.1111/jnc.13096
(check this in PDF content)
45
McKenna M, Rae C. A new role for α-ketoglutarate dehydrogenase complex: regulating metabolism through posttranslational modification of other enzymes. J Neurochem 2015; 134(1): 3-6. doi: 10.1111/jnc.13150 Сведения об авторах:
(check this in PDF content)